80 FR 38219 - Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 127 (July 2, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 127 (July 2, 2015)
| Page Range | 38219-38219 | |
| FR Document | 2015-16351 |
[Federal Register Volume 80, Number 127 (Thursday, July 2, 2015)] [Notices] [Page 38219] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-16351] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on July 29, 2015. The topic for this meeting will be ``New Opportunities for Clinical Research on Type 2 Diabetes.'' The meeting is open to the public. DATES: The meeting will be held on July 29, 2015 from 1:00 p.m. to 4:30 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. ADDRESSES: The meeting will be held in the Democracy 2 Building at 6707 Democracy Blvd., Bethesda, MD, in Conference Room 701. FOR FURTHER INFORMATION CONTACT: For further information concerning this meeting, see the DMICC Web site, www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496- 6623; FAX: 301-480-6741; email: [email protected]. SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The July 29, 2015 DMICC meeting will focus on New Opportunities for Clinical Research on Type 2 Diabetes. Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first-come, first-serve basis. Members of the public who would like to receive email notification about future DMICC meetings should register for the listserv available on the DMICC Web site, www.diabetescommittee.gov. Dated: June 26, 2015. B. Tibor Roberts, Executive Secretary, DMICC, Office of Scientific Program and Policy Analysis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. [FR Doc. 2015-16351 Filed 7-1-15; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 80, No. 127 / Thursday, July 2, 2015 / Notices 38219
Name of Committee: Center for Scientific FOR FURTHER INFORMATION CONTACT: For Dated: June 26, 2015.
Review Special Emphasis Panel; Member further information concerning this B. Tibor Roberts,
Conflict: Cardiovascular Sciences. meeting, see the DMICC Web site, Executive Secretary, DMICC, Office of
Date: July 23, 2015. www.diabetescommittee.gov, or contact Scientific Program and Policy Analysis,
Time: 8:00 a.m. to 5:00 p.m.
Dr. B. Tibor Roberts, Executive National Institute of Diabetes and Digestive
Agenda: To review and evaluate grant
Secretary of the Diabetes Mellitus and Kidney Diseases, National Institutes of
applications.
Interagency Coordinating Committee, Health.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, National Institute of Diabetes and [FR Doc. 2015–16351 Filed 7–1–15; 8:45 am]
(Virtual Meeting). Digestive and Kidney Diseases, 31 BILLING CODE 4140–01–P
Contact Person: Lawrence E. Boerboom, Center Drive, Building 31A, Room
Ph.D., Chief, CVRS IRG, Center for Scientific 9A19, MSC 2560, Bethesda, MD 20892–
Review, National Institutes of Health, 6701 2560, telephone: 301–496–6623; FAX: DEPARTMENT OF HEALTH AND
Rockledge Drive, Room 4130, MSC 7814, 301–480–6741; email: dmicc@ HUMAN SERVICES
Bethesda, MD 20892, (301) 435–8367,
boerboom@nih.gov.
mail.nih.gov.
National Institutes of Health
Name of Committee: Center for Scientific SUPPLEMENTARY INFORMATION: The
Review Special Emphasis Panel; Member DMICC, chaired by the National Center for Scientific Review; Notice of
Conflict: Mechanisms of Aging. Institute of Diabetes and Digestive and Closed Meetings
Date: July 28, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Kidney Diseases (NIDDK) comprising Pursuant to section 10(d) of the
Agenda: To review and evaluate grant members of the Department of Health Federal Advisory Committee Act, as
applications. and Human Services and other federal amended (5 U.S.C. App.), notice is
Place: National Institutes of Health, 6701 agencies that support diabetes-related hereby given of the following meetings.
Rockledge Drive, Bethesda, MD 20892, activities, facilitates cooperation,
The meetings will be closed to the
(Telephone Conference Call). communication, and collaboration on
Contact Person: Thomas Beres, Ph.D., public in accordance with the
diabetes among government entities.
Scientific Review Officer, Center for provisions set forth in sections
DMICC meetings, held several times a
Scientific Review, National Institutes of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
year, provide an opportunity for
Health, 6701 Rockledge Dr., Rm. 5201, MSC as amended. The grant applications and
7840, Bethesda, MD 20892, 301–435–1175,
Committee members to learn about and
the discussions could disclose
berestm@mail.nih.gov. discuss current and future diabetes
confidential trade secrets or commercial
(Catalogue of Federal Domestic Assistance
programs in DMICC member
property such as patentable material,
Program Nos. 93.306, Comparative Medicine; organizations and to identify
and personal information concerning
93.333, Clinical Research, 93.306, 93.333, opportunities for collaboration. The July
individuals associated with the grant
93.337, 93.393–93.396, 93.837–93.844, 29, 2015 DMICC meeting will focus on
applications, the disclosure of which
93.846–93.878, 93.892, 93.893, National New Opportunities for Clinical Research
would constitute a clearly unwarranted
Institutes of Health, HHS) on Type 2 Diabetes.
invasion of personal privacy.
Dated: June 26, 2015. Any member of the public interested
Name of Committee: Center for Scientific
Anna Snouffer, in presenting oral comments to the
Review Special Emphasis Panel; CVRS
Deputy Director, Office of Federal Advisory Committee should notify the contact Member Conflicts and Continuous
Committee Policy. person listed on this notice at least 10 Submissions.
[FR Doc. 2015–16212 Filed 7–1–15; 8:45 am] days in advance of the meeting. Date: July 8, 2015.
BILLING CODE 4140–01–P Interested individuals and Time: 3:00 p.m. to 5:00 p.m.
representatives or organizations should Agenda: To review and evaluate grant
submit a letter of intent, a brief applications.
DEPARTMENT OF HEALTH AND description of the organization Place: National Institutes of Health, 6701
represented, and a written copy of their Rockledge Drive, Bethesda, MD 20892,
HUMAN SERVICES
(Telephone Conference Call).
oral presentation in advance of the
Contact Person: Olga A. Tjurmina, Ph.D.,
National Institutes of Health meeting. Only one representative of an Scientific Review Officer, Center for
organization will be allowed to present; Scientific Review, National Institutes of
Notice of Diabetes Mellitus Interagency oral comments and presentations will be Health, 6701 Rockledge Drive, Room 4138,
Coordinating Committee Meeting limited to a maximum of 5 minutes. MSC 7814, Bethesda, MD 20892, (301) 451–
Printed and electronic copies are 1375, ot3d@nih.gov.
SUMMARY: The Diabetes Mellitus This notice is being published less than 15
requested for the record. In addition,
Interagency Coordinating Committee days prior to the meeting due to the timing
any interested person may file written
(DMICC) will hold a meeting on July 29, limitations imposed by the review and
comments with the Committee by
2015. The topic for this meeting will be funding cycle.
forwarding their statement to the
‘‘New Opportunities for Clinical Name of Committee: Center for Scientific
contact person listed on this notice. The
Research on Type 2 Diabetes.’’ The Review Special Emphasis Panel;
statement should include the name,
meeting is open to the public. Cardiovascular and Respiratory Sciences
address, telephone number and when AREA.
DATES: The meeting will be held on July applicable, the business or professional Date: July 13–14, 2015.
29, 2015 from 1:00 p.m. to 4:30 p.m. affiliation of the interested person. Time: 8:00 a.m. to 4:00 p.m.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Individuals wanting to present oral Because of time constraints for the Agenda: To review and evaluate grant
comments must notify the contact meeting, oral comments will be allowed applications.
person at least 10 days before the on a first-come, first-serve basis. Place: National Institutes of Health, 6701
meeting date. Rockledge Drive, Bethesda, MD 20892,
Members of the public who would (Virtual Meeting).
ADDRESSES: The meeting will be held in like to receive email notification about Contact Person: Sara Ahlgren, Ph.D.,
the Democracy 2 Building at 6707 future DMICC meetings should register Scientific Review Officer, Center for
Democracy Blvd., Bethesda, MD, in for the listserv available on the DMICC Scientific Review, National Institutes of
Conference Room 701. Web site, www.diabetescommittee.gov. Health, 6701 Rockledge Drive, RM 4136,
VerDate Sep<11>2014 21:16 Jul 01, 2015 Jkt 235001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\02JYN1.SGM 02JYN1](https://thefederalregister.org/doc/80_FR_38346/page/1.svg)
Document Created: 2015-12-15 13:16:17
Document Modified: 2015-12-15 13:16:17
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | The meeting will be held on July 29, 2015 from 1:00 p.m. to 4:30 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. | |
| Contact | For further information concerning this meeting, see the DMICC Web site, www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496- 6623; FAX: 301-480-6741; email: [email protected] | |
| FR Citation | 80 FR 38219 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR